Archive | Redefining Early Stage Investments RSS feed for this section

Global Family Office BioForum Joins RESI Asia

10 Oct

Interview with Chuck Stetson, CEO of Stetson Family Office

By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series

Click to see part one of a two part interview with Chuck Stetson, CEO, Stetson Family Office and Founder of the Global Family Office BioForum (GFOB). Chuck, who is the third generation running the Stetson Family Office, is an entrepreneur, venture capitalist, and philanthropist. GFOB helps make more high quality investments in the life science arena by connecting regional family offices with regional angel groups, incubators and accelerators – essentially helping family offices around the globe participate in the funding of early stage technology assets located in their local healthcare tech hubs.

This interview, conducted by Dennis Ford, CEO, Life Science Nation and Creator of the Redefining Early Stage Investments (RESI) Conference Series, is a deep dive into how a family office views and participates in funding startups.  Chuck will be representing the GFOB at both RESI Asia events – Shanghai, November 12th and Taipei, November 14th. Click here to register for the events.

FOUR Chances to Present at RESI Asia!

10 Oct

By Gregory Mannix, Vice President International Business Development, LSN

That’s right – RESI Asia will, for the first time, allow participants to present their companies four times over the course of two days. By applying to the Innovation Challenge for RESI Asia, companies will get the chance to present a poster in the exhibition hall AND pitch to a panel of investors at both the Shanghai RESI conference on November 12th and the Taipei RESI conference on November 14th. That is an incredible opportunity to get visibility for your company and meet with many investors and strategics from China, Asia-Pacific and beyond.

We know from experience that companies that compete as finalists in the Innovation Challenge at a RESI conference get more visibility and more one-on-one meetings with investors. The opportunity this November, with two conferences back-to-back in two hot life science hubs in Asia, is UNPRECEDENTED.

As always, participating in the RESI Innovation Challenge carries no additional cost for companies. You’ve got nothing to lose, and everything to gain!

New Healthcare Breakthroughs From All Over the World on Show at RESI Asia

10 Oct

By Lucy Parkinson, VP of Investor Research, LSN

When LSN decided to bring RESI to Asia, we aimed to provide far more than a regional networking hub. Through our relationships with investors and technology hubs worldwide, we knew that many investment firms are looking to Asia as a source of new technologies – and conversely, many investors and major corporations based in Asia want to meet early stage startups from other parts of the world.

Due to the outreach LSN’s team has performed to technology hubs and early stage companies, RESI Asia is building up to a global showcase of early stage drugs, devices, diagnostics, and digital health innovations. We hope you can join us in Shanghai and Taipei to meet these entrepreneurs face to face.

RESI ASIA Therapeutics Companies
RESI ASIA Medical Device Companies
RESI ASIA Diagnostics Companies
RESI ASIA Digital Health Companies
RESI ASIA Service Providers

And More…

%d bloggers like this: